Glioblastoma Treatments: An Account of Recent Industrial Developments

Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy

(2018) David Thibouw et al.   JOURNAL OF NEURO-ONCOLOGY

Costes indirectos asociados al glioblastoma. Experiencia en un centro

(2018) J. Undabeitia et al.   NEUROLOGIA

Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma—Foundations and Future

(2018) Gayle R. Salama et al.   Frontiers in Neurology

Advances in Radiotherapy for Glioblastoma

(2018) Justin Mann et al.   Frontiers in Neurology

Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma

(2018) Gloria C. Chiang et al.   Frontiers in Neurology

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy

(2018) Michele Patrizii et al.   Frontiers in Oncology

Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors

(2018) Laura Benson   Seminars in Oncology Nursing

The Safety of available immunotherapy for the treatment of glioblastoma

(2017) S. Harrison Farber et al.   Expert Opinion On Drug Safety

The cost and value of glioblastoma therapy

(2017) Daniel N. Cagney et al.   Expert Review of Anticancer Therapy

Laser neurosurgery: A systematic analysis of magnetic resonance-guided laser interstitial thermal therapies

(2017) Carlito Lagman et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field

(2017) Edouard Alphandéry et al.   JOURNAL OF CONTROLLED RELEASE

Immunotherapy and radiation in glioblastoma

(2017) Solmaz Sahebjam et al.   JOURNAL OF NEURO-ONCOLOGY

The role of bevacizumab in the treatment of glioblastoma

(2017) Roberto Jose Diaz et al.   JOURNAL OF NEURO-ONCOLOGY

Advances in immunotherapeutic research for glioma therapy

(2017) Jeremy Tetsuo Miyauchi et al.   JOURNAL OF NEUROLOGY

ACT IV: the final act for rindopepimut?

(2017) Elizabeth R Gerstner   LANCET ONCOLOGY

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

(2017) Nico van Zandwijk et al.   LANCET ONCOLOGY

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

(2017) Karsten Geletneky et al.   MOLECULAR THERAPY

Vaccine-based immunotherapeutic approaches to gliomas and beyond

(2017) Michael Weller et al.   Nature Reviews Neurology

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

(2017) Maria-Carmela Speranza et al.   NEURO-ONCOLOGY

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

(2017) Kei Hiraoka et al.   NEURO-ONCOLOGY

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas

(2017) Matthias Holdhoff et al.   NEURO-ONCOLOGY

Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model

(2017) Leah A. Mitchell et al.   NEURO-ONCOLOGY

Awake Craniotomy vs Craniotomy Under General Anesthesia for Perirolandic Gliomas: Evaluating Perioperative Complications and Extent of Resection

(2017) Chikezie I. Eseonu et al.   NEUROSURGERY

Cancer-selective, single agent chemoradiosensitising gold nanoparticles

(2017) Sophie Grellet et al.   PLoS One

Treatment of meningioma and glioma with protons and carbon ions

(2017) Sebastian Adeberg et al.   Radiation Oncology

Strategies of temozolomide in future glioblastoma treatment

(2017) Chooi Yeng Lee   OncoTargets and Therapy

Endoscopic optical coherence tomography: technologies and clinical applications [Invited]

(2017) Michalina J. Gora et al.   Biomedical Optics Express

Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma

(2017) Raphaël Le Fèvre et al.   Theranostics

Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence

(2017) Atsushi Fukui et al.   World Neurosurgery

Targeted Nanotechnology in Glioblastoma Multiforme

(2017) Talita Glaser et al.   Frontiers in Pharmacology

History and current state of immunotherapy in glioma and brain metastasis

(2017) Tresa McGranahan et al.   Therapeutic Advances in Medical Oncology

SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI

(2017) Lei Deng et al.   NEOPLASIA

Immunotherapy approaches in the treatment of malignant brain tumors

(2016) Anastasie M. Dunn-Pirio et al.   CANCER

Concepts in glioma immunotherapy

(2016) Michael Platten et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

(2016) Robert A. Fenstermaker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma

(2016) R. Rampling et al.   CLINICAL CANCER RESEARCH

Recent advances and future of immunotherapy for glioblastoma

(2016) Neha Kamran et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Emerging immunotherapies for glioblastoma

(2016) Rupen Desai et al.   EXPERT OPINION ON EMERGING DRUGS

Investigational new drugs for brain cancer

(2016) Verena Staedtke et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

(2016) Ulrich Herrlinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma

(2016) Surasak Phuphanich et al.   JOURNAL OF NEURO-ONCOLOGY

Advances in immunotherapy for the treatment of glioblastoma

(2016) Amanda Tivnan et al.   JOURNAL OF NEURO-ONCOLOGY

Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation

(2016) Ted K. Yanagihara et al.   JOURNAL OF NEURO-ONCOLOGY

Neuro-oncology biotech industry progress report

(2016) Shamik Chakraborty et al.   JOURNAL OF NEURO-ONCOLOGY

Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model

(2016) Mitsuto Hanihara et al.   JOURNAL OF NEUROSURGERY

Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system

(2016) Purvee Patel et al.   JOURNAL OF NEUROSURGERY

Worldwide collaboration for orphan drug designation

(2016) Segundo Mariz et al.   NATURE REVIEWS DRUG DISCOVERY

Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models

(2016) Kader Yagiz et al.   NEURO-ONCOLOGY

Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma

(2016) Tracy T. Batchelor et al.   NEURO-ONCOLOGY

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models

(2016) Yuji Piao et al.   NEURO-ONCOLOGY

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma

(2016) Tara A. Barone et al.   NEURO-ONCOLOGY

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma

(2016) F. Bernard-Arnoux et al.   NEURO-ONCOLOGY

Microglia and brain macrophages: An update

(2016) Atsushi Sasaki   NEUROPATHOLOGY

Intraoperative Probe-Based Confocal Laser Endomicroscopy in Surgery and Stereotactic Biopsy of Low-Grade and High-Grade Gliomas

(2016) Vladislav Pavlov et al.   NEUROSURGERY

“Tag Team” Glioblastoma Therapy

(2016) Joslyn K. Strebe et al.   NEUROSURGERY

Current and future strategies for treatment of glioma

(2016) Nancy Ann Oberheim Bush et al.   NEUROSURGICAL REVIEW

The role of brachytherapy in the treatment of glioblastoma multiforme

(2016) Eric Barbarite et al.   NEUROSURGICAL REVIEW

Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier

(2016) Eric C. Leuthardt et al.   PLoS One

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

(2016) Teresa E. Peterson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR

(2016) Timothy P. Heffron et al.   ACS Medicinal Chemistry Letters

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles

(2016) Víctor M. Blanco et al.   Oncotarget

Treatment of Glioma Using neuroArm Surgical System

(2016) Yaser Maddahi et al.   Biomed Research International

Glioblastoma after AVM radiosurgery. Case report and review of the literature

(2015) Artur Xhumari et al.   ACTA NEUROCHIRURGICA

Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro

(2015) Christian Merz et al.   ANTI-CANCER DRUGS

Potential use of glioblastoma tumorsphere: clinical credentialing

(2015) Seok-Gu Kang et al.   ARCHIVES OF PHARMACAL RESEARCH

Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model

(2015) Tiffany T. Huang et al.   HUMAN GENE THERAPY

Overview of current immunotherapeutic strategies for glioma

(2015) Anda-Alexandra Calinescu et al.   Immunotherapy

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

(2015) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma

(2015) James R. Whittle et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme

(2015) Bruno Kovic et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas

(2015) Yazmin Odia et al.   JOURNAL OF NEURO-ONCOLOGY

Location of brain tumor intersecting white matter tracts predicts patient prognosis

(2015) Nikolai J. Mickevicius et al.   JOURNAL OF NEURO-ONCOLOGY

VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme

(2015) Aleksandra Gruslova et al.   JOURNAL OF NEURO-ONCOLOGY

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

(2015) B. D. Smith et al.   MOLECULAR CANCER THERAPEUTICS

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

(2015) E. Q. Lee et al.   NEURO-ONCOLOGY

A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma

(2015) Elizabeth R. Gerstner et al.   NEURO-ONCOLOGY

Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma

(2015) Rajneet K. Oberoi et al.   NEURO-ONCOLOGY

Immunomodulation: checkpoint blockade etc.: Fig. 1.

(2015) William T. Curry et al.   NEURO-ONCOLOGY

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

(2015) J. Schuster et al.   NEURO-ONCOLOGY

Convection-enhanced delivery for the treatment of glioblastoma

(2015) M. A. Vogelbaum et al.   NEURO-ONCOLOGY

Glioblastoma multiforme: Pathogenesis and treatment

(2015) Constantinos Alifieris et al.   PHARMACOLOGY & THERAPEUTICS

Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz)

(2015) Lukas Winter et al.   Radiation Oncology

Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography

(2015) Carmen Kut et al.   Science Translational Medicine

First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity

(2015) Virgil E.J.C. Schijns et al.   VACCINE

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme

(2015) Liu Yang et al.   Biomed Research International

Immunotherapy for cancer in the central nervous system: Current and future directions

(2015) David C. Binder et al.   OncoImmunology

Economics of Malignant Gliomas: A Critical Review

(2015) Jeffrey J. Raizer et al.   Journal of Oncology Practice

Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors

(2015) Víctor M. Blanco et al.   Oncotarget

The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients

(2015) Michelle Paff et al.   Human Vaccines & Immunotherapeutics

Comparison of Linear Accelerator and Helical Tomotherapy Plans for Glioblastoma Multiforme Patients

(2014) Timur Koca et al.   Asian Pacific Journal of Cancer Prevention

Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma

(2014) J. R. Van Brocklyn et al.   CANCER RESEARCH

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

(2014) W. Wick et al.   CLINICAL CANCER RESEARCH

Clinical and Practical Considerations for the Use of Intensity-modulated Radiotherapy and Image Guidance in Neuro-oncology

(2014) N.G. Burnet et al.   CLINICAL ONCOLOGY

Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019

(2014) Donatella Vecchio et al.   INTERNATIONAL JOURNAL OF CANCER

Immunocompetent murine models for the study of glioblastoma immunotherapy

(2014) Taemin Oh et al.   Journal of Translational Medicine

Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy

(2014) B. Thaci et al.   NEURO-ONCOLOGY

Navigated transcranial magnetic stimulation improves the treatment outcome in patients with brain tumors in motor eloquent locations

(2014) D. Frey et al.   NEURO-ONCOLOGY

Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma

(2014) Adam L. Green et al.   NEURO-ONCOLOGY

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

(2014) D. A. Reardon et al.   NEURO-ONCOLOGY

Immunotherapy advances for glioblastoma

(2014) D. A. Reardon et al.   NEURO-ONCOLOGY

DCVax®-L—Developed by Northwest Biotherapeutics

(2014) Stavros Polyzoidis et al.   Human Vaccines & Immunotherapeutics

KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis

(2014) Seon Rang Woo et al.   Biomed Research International

Extracts from Glioma Tissues following Cryoablation Have Proapoptosis, Antiproliferation, and Anti-Invasion Effects on Glioma Cells

(2014) Tianzhu Liu et al.   Biomed Research International

The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study

(2014) Alireza M. Mohammadi et al.   Cancer Medicine

DTI of the Visual Pathway - White Matter Tracts and Cerebral Lesions

(2014) Ardian Hana et al.   Jove-Journal of Visualized Experiments

Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma

(2014) Luis Marrero et al.   NEOPLASIA

The role of Gliadel wafers in the treatment of high-grade gliomas

(2013) Amade Bregy et al.   Expert Review of Anticancer Therapy

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

(2013) Tracy T. Batchelor et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma

(2013) Andrew E. Sloan et al.   JOURNAL OF NEUROSURGERY

Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma

(2013) Jeffrey Wojton et al.   MOLECULAR THERAPY

New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma

(2013) Takuichiro HIDE et al.   NEUROLOGIA MEDICO-CHIRURGICA

Clinical Outcomes of Gamma Knife Radiosurgery in the Salvage Treatment of Patients with Recurrent High-Grade Glioma

(2013) Ameer L. Elaimy et al.   World Neurosurgery

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

(2012) Surasak Phuphanich et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control

(2012) Sarah E. Golding et al.   CELL CYCLE

Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients

(2012) Andreas M. Stark et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

(2012) T. E. Taylor et al.   CURRENT CANCER DRUG TARGETS

MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas

(2012) Alexandre Carpentier et al.   LASERS IN SURGERY AND MEDICINE

In vivo models of primary brain tumors: pitfalls and perspectives

(2012) P. C. Huszthy et al.   NEURO-ONCOLOGY

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1

(2011) Y Bertrand et al.   BRITISH JOURNAL OF CANCER

Intradermal delivery of vaccines: potential benefits and current challenges

(2011) JK Hickling et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

European regulation on orphan medicinal products: 10 years of experience and future perspectives

(2011)   NATURE REVIEWS DRUG DISCOVERY

A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas

(2011) Teri N. Kreisl et al.   NEURO-ONCOLOGY

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

(2011) H. Wakimoto et al.   NEURO-ONCOLOGY

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

(2011) N. Butowski et al.   NEURO-ONCOLOGY

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

(2011) D. Ostertag et al.   NEURO-ONCOLOGY

The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival

(2011) Kaisorn L Chaichana et al.   NEUROLOGICAL RESEARCH

Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

(2011) Jan-Karl Burkhardt et al.   World Neurosurgery

Guidelines for the welfare and use of animals in cancer research

(2010) P Workman et al.   BRITISH JOURNAL OF CANCER

The perivascular niche microenvironment in brain tumor progression

(2010) Nikki A Charles et al.   CELL CYCLE

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

(2010) Wolfgang Wick et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar

(2010) Xi Fei et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

(2010) John A. Boockvar et al.   JOURNAL OF NEUROSURGERY

Development of Stereotactic Mass Spectrometry for Brain Tumor Surgery

(2010) Nathalie Y.R. Agar et al.   NEUROSURGERY

Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues

(2010) Dante Amelio et al.   RADIOTHERAPY AND ONCOLOGY

Awake Craniotomy, Electrophysiologic Mapping, and Tumor Resection With High-Field Intraoperative MRI

(2010) Ian F. Parney et al.   World Neurosurgery

Evaluation of the exposure equivalence of oral versus intravenous temozolomide

(2009) Blanca D. Diez et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

New strategies to deliver anticancer drugs to brain tumors

(2009) Valentino Laquintana et al.   Expert Opinion on Drug Delivery

Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice

(2009) Walid S. Kamoun et al.   JOURNAL OF CLINICAL ONCOLOGY

Spontaneous canine gliomas: overexpression of EGFR, PDGFRα and IGFBP2 demonstrated by tissue microarray immunophenotyping

(2009) Robert J. Higgins et al.   JOURNAL OF NEURO-ONCOLOGY

Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

(2009) Rolf F. Barth et al.   JOURNAL OF NEURO-ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Identification of Cancer Stem Cells in Dog Glioblastoma

(2009) G. Stoica et al.   VETERINARY PATHOLOGY

Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2

(2008) A Régina et al.   BRITISH JOURNAL OF PHARMACOLOGY

Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats

(2008) Aditya Bansal et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model

(2008) Maria Sandström et al.   JOURNAL OF NEURO-ONCOLOGY

Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases

(2008) Kazuhiro Miwa et al.   JOURNAL OF NEURO-ONCOLOGY

Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging

(2008) Peter J. Dickinson et al.   JOURNAL OF NEUROSURGERY

Immunohistochemical and ultrastructural characterization of brain tumors in S100β-v-erbB transgenic rats

(2008) Hideaki Yokoo et al.   NEUROPATHOLOGY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE